NCT04127344

Brief Summary

The hypothesis is that the music therapy intervention has a positive impact on the critical patients' mood as it has a reassuring effect that allows a connection with emotions, helps to communicate and affects the welfare of patients. It also reduces pain and the consumption of painkillers and sedatives, as well as vasoactive drugs in critical patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 15, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

March 4, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

August 29, 2019

Last Update Submit

March 3, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mood state

    The mood state will be assessed through the Profile of Mood States Scale (POMS) after randomization, within the next 6 to 12 hours, and 24 hours after randomization.

    24 hours

Secondary Outcomes (4)

  • Level of pain

    24 hours

  • Consumption of analgesics and sedatives

    24 hours

  • Consumption of vasoactive drugs

    24 hours

  • Physiological variables (blood pressure, heart rate, breathing rate and oxygen saturation)

    24 hours

Study Arms (2)

Music Therapy Intervention

EXPERIMENTAL

Patients enrolled will be randomised between two arms: Music Therapy Intervention and Non-Music Therapy Intervention. Patients randomised to a music therapy intervention will receive an individualised music therapy intervention.

Behavioral: Music Therapy Intervention

Non-Music Therapy Intervention

NO INTERVENTION

Patients enrolled will be randomised between two arms: Music Therapy Intervention and Non-Music Therapy Intervention. Patients allocated to Non-Music Therapy Intervention received standard treatment.

Interventions

Patients randomized to a music therapy intervention will receive an individualised music therapy intervention. The sessions will last 10-20 minutes and they will be done by music therapist and musician.

Music Therapy Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are oriented in time, space and person
  • Glasgow Coma Scale of 15 or 11+intubated
  • Negative the Confusion Assessment Method for the ICU (CAM-ICU)
  • Richmond Agitation-Sedation Scale of 0
  • Patients who are at least conscious and oriented for 48 hours in the ICU.

You may not qualify if:

  • Auditory deficit
  • Patients that have participated in the study previously

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, 08025, Spain

RECRUITING

Study Officials

  • Mª del Mar Vega Castosa

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mª del Mar Vega Castosa

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized clinical trial, parallel and open label.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2019

First Posted

October 15, 2019

Study Start

March 12, 2019

Primary Completion

March 12, 2020

Study Completion

December 31, 2020

Last Updated

March 4, 2020

Record last verified: 2020-03

Locations